CA9 and cancer: CA9 expression is primarily driven by HIF-1 activity, and it is thought to be a particularly promising therapeutic target in cancer because it is not detected in most normal tissues, but its expression in tumor tissue delineates hypoxic regions and correlates with advanced disease and poor treatment response13–18.